RxDoctor Payments Data

Louis Raymond, MD

Nephrology · Rapid City, SDNPI 1760437016

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Baxter Healthcare at 55.5% of the total. Reporting peaked in 2022 at $133 and has fallen 58.1% since, to $56 in 2024.

$313in general payments, 2019–2025

Across 7 payments — averaging $44.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$174
  • Bayer$125
  • Amgen$14
$26,911in research payments, 2019–2025

Across 6 payments — averaging $4485.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$27K
  • Boehringer Ingelheim International GmbH$13

What the payments were for

  • Food & beverage$313100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Baxter Healthcare5$174
Bayer1$125
Amgen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$313 in reported general payments places this provider in the 60th percentile of 26 nephrology providers in South Dakota.

See all nephrology providers in South Dakota

Medicare billing

Part B allowed, 2024
$323,029
Medicare patients
214
Services billed
1,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$28,036
EliquisApixaban26$17,105
RenvelaSevelamer Carbonate11$11,696
VeltassaPatiromer Calcium Sorbitex12$6,272
Sevelamer Carbonate52$4,451
Calcium Acetate62$4,403
Tacrolimus24$3,545
Bumetanide63$2,922
Clonidine26$2,418
LoperamideLoperamide Hcl44$1,293
SynthroidLevothyroxine Sodium45$1,231
Metoprolol Succinate95$978
Losartan Potassium129$937
Amlodipine Besylate171$877
Atorvastatin Calcium95$814

Paid to pharmacies, not to this prescriber.

Other nephrology in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →